Lung large cell carcinoma
MONDO:0003050A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation. There is a male predilection.
Also known as: anaplastic lung carcinoma, large cell carcinoma of lung, large cell carcinoma of the lung, large cell lung cancer, large cell lung carcinoma, large cell undifferentiated lung carcinoma, lung large cell carcinoma, LCLC
2833 clinical trials for this condition and its sub-types, 11 tagged with Lung large cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lung large cell carcinoma
-
1 sub-type
-
Lung sarcomatoid carcinoma 3 trials · 7 incl. sub-types
3 sub-types
- Pulmonary blastoma 1 trial · 4 incl. sub-types Sub-types →
- Lung giant cell carcinoma 1 trial
- Lung pleomorphic carcinoma 1 trial
-
Basaloid large cell lung carcinoma 0 trials
-
Lung occult large cell carcinoma 0 trials
Most studied deeper sub-types
-
Could a diabetes drug boost lung cancer treatment?
Disease control CompletedThis study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation helps people with stage III non-small cell lung cancer live longer without their cancer getting worse. About 170 adults with advanced lung cancer took part. The goal …
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a PARP inhibitor boost chemo for tough lung cancer?
Disease control CompletedThis study tested whether adding veliparib (a PARP inhibitor) to standard chemotherapy (cisplatin and etoposide) helps people with extensive stage small cell lung cancer or certain other lung cancers that have spread. In the first phase, researchers found the best dose of velipar…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC